Mesoblast Ltd’s Share Price Climbs 5% on Fast Track Approval

Mesoblast Ltd [ASX:MSB] is a global leader in developing innovative cell-based medicines. Today, the stock climbed more than 5%, to $1.88. Investors in MSB are now sitting on returns of 31.47% year-to-date. Not bad for a little over two months into the year.

What happened to the Mesoblast share price?

Today, MSB announced that the Food and Drug Administration (FDA) has granted a ‘fast track’ designation for the use of its cell therapy, MSC-100-IV.

The therapy aims to benefit children with steroid refractory acute Graft Versus Host Disease. The fast track designation has the potential to shorten FDA approval time.

Should you buy Mesoblast shares?

MSB said their MSC-100-IV cell therapy could lead to commercial benefit for the company. At this point, it’s hard to tell how it could impact earnings. That’s why I suggest waiting for more information before jumping in.

Regards,

Härje Ronngard,

Junior Analyst, Money Morning

PS: It’s not always easy to find growth among billion-dollar stocks. Unless they can significantly increase earnings, you’d be lucky to get double-digit returns. That’s why some investors prefer the smaller end of the market.

Small-cap stocks are a riskier investment. There is no running away from it. But they can potentially grow earnings 10-fold in a short space of time.

Small-cap specialist Sam Volkering has been on the other end of small-caps running up 1,000% or more.

So far in 2017, Sam hasn’t recommended a losing stock yet. In his advisory service, Australian Small-Cap Investigator, his top three active investments are up 304.57%, 466.04% and 1,624.49%.

To find out more, click here.

[ampBannerMM]


Money Morning is Australia’s most outspoken financial news service. Your Money Morning editorial team are not afraid to tell it like it is. From calling out politicians to taking on the housing industry, our aim is to cut through the hype and BS to help you make sense of the stories that make a difference to your wealth. Whether you agree with us or not, you’ll find our common-sense, thought provoking arguments well worth a read.

Money Morning Australia is published by Port Phillip Publishing, an independent financial publisher based in Melbourne, Australia. As an Australian financial services license holder we are subject to the regulations and laws of Corporations Act and Financial Services Act.


Money Morning Australia